import MCQGroup from '@/components/MCQGroup'
import { Callout } from 'nextra/components'

# Kaposi’s Sarcoma (KS)

Kaposi’s sarcoma (KS) is a low-grade neoplasm associated with **human herpesvirus-8 (HHV-8)**. It is characterized as a **vasoformative tumor**, originating in the vascular system and composed of vasoformative tumor cells, abnormal vessels, and chronic inflammatory cells.

## Subtypes of Kaposi’s Sarcoma

There are four main subtypes of KS:

1. **Epidemic AIDS-related KS**
   - Occurs in individuals who are **HIV-positive**.
   - The incidence has decreased with the increased use of **anti-retroviral therapy (ART)**, but remains high in sub-Saharan Africa where ART availability is limited.
   
2. **Classic sporadic KS**
   - Unrelated to HIV infection.
   - Primarily occurs in older men of **Jewish or Mediterranean ancestry**.
   
3. **Iatrogenic or transplant-associated KS**
   - Associated with **immunosuppressants**.
   - Most commonly seen following **solid organ transplantation**.
   
4. **African endemic KS**
   - Unrelated to HIV.
   - Typically observed in **central Africa**.

## Clinical Presentation

Lesions in KS usually begin as patches and can progress to plaques and ultimately ulcerating tumor nodules. They may become extensive, involving **lymph nodes** and **visceral organs**.

### Common Signs and Symptoms

<details>
<summary>Common Signs and Symptoms</summary>

- **Mucocutaneous Lesions**:
  - Asymmetrical distribution
  - Color: Pink-purple nodules to purple-brown plaques
  - Size and shape variability: Nodular, papular, plaque-like, ulcerated

- **Lymphadenopathy**:
  - Swelling may occur in legs, genitalia, and face.

- **Oral Lesions**:
  - Potential bleeding and ulceration, affecting swallowing and speech.

- **Gastrointestinal Involvement**:
  - Symptoms include weight loss, abdominal pain, nausea, vomiting, and diarrhea.

- **Pulmonary Involvement**:
  - May present with cough, dyspnea, hemoptysis, and chest pain.

</details>

## Diagnosis

KS is typically diagnosed through:

- **Identification of lesions**.
- Recognizing the **clinical category** (subtype of KS).
- Confirming with **biopsy** and **histopathology**.

### Biopsy Characteristics

- Show characteristic atypical **spindle-shaped cells**.
- Perform biopsies to exclude other conditions.

<Callout emoji="⚠️">
**Warning:** Cutaneous lesions in KS tend not to be painful or pruritic, leading to increased risk of late diagnosis.
</Callout>

## Investigations

- **HIV Testing**:
  - Mandatory for any patient presenting with KS.
- **CD4 Count** and **Viral Load**:
  - Specifically in known HIV-positive patients, as KS is considered an **AIDS-defining illness**.
- **Additional Investigations**:
  - Fecal occult blood test for GI lesions.
  - Chest X-ray for pleural effusions or lymphadenopathy.

## Management (Non-Prescribing)

- **Antiretroviral Therapy (ART)**:
  - Strongly recommended regardless of CD4 count.
  - Important for optimal control of HIV infection, especially in **AIDS-related KS**.

- **Surgical Options**:
  - Reserved for cosmetically unsightly lesions or to manage discomfort.
  - Alternatives include **laser therapy** and **cryotherapy**.

- **Systemic Treatment**:
  - Indicated for extensive involvement (>25 separate lesions), symptomatic edema, or visceral disease.
  - **Liposomal anthracyclines** are first-line chemotherapeutic agents.

- **Radiotherapy**:
  - Can be utilized if chemotherapy is intolerable or for symptomatic palliation.

## References

- [BMJ Best Practice - Epidemiology of Kaposi's Sarcoma](https://bestpractice.bmj.com/topics/en-gb/1031/epidemiology)
- [Oxford Medicine - Non-AIDS Associated Kaposi's Sarcoma: Clinical Features and Treatment Outcome](https://oxfordmedicine.com/view/10.1093/med/9780198719021.001.0001/med-9780198719021-chapter-8?rskey=BSC3TI&result=1)

---

<MCQGroup questions={[
  {
    question: "Which of the following is a characteristic feature of Kaposi’s sarcoma (KS) lesions?",
    options: [
      "Lesions tend to be painful and pruritic.",
      "Lesions typically do not bleed unless ulcerated.",
      "Lesions are uniformly distributed across the body.",
      "Lesions usually appear as well-defined solitary nodules."
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! Kaposi’s sarcoma lesions typically do not have associated pain or itching, which can result in a delayed diagnosis. They often present as asymmetrical, non-painful lesions that can vary in color and size.",
    incorrectFeedback: "Consider the typical presentation of KS lesions and their characteristics. Are they usually painful? What is their usual distribution on the body?"
  },
  {
    question: "In patients with HIV-associated Kaposi's sarcoma, what is the most critical initial step in management?",
    options: [
      "Chemotherapy with liposomal anthracyclines.",
      "Surgical excision of the lesions.",
      "Initiation of antiretroviral therapy (ART).",
      "Radiotherapy for localized lesions."
    ],
    correctAnswer: 3,
    correctFeedback: "Correct! Initiating antiretroviral therapy (ART) is crucial for managing HIV, which can control the progression of AIDS-related Kaposi’s sarcoma by improving immune function and decreasing viral load.",
    incorrectFeedback: "Think about the underlying cause of KS in this context. What primary treatment should be prioritized to address the immune deficiency related to HIV infection?"
  },
  {
    question: "A 58-year-old man presents with non-painful, purple-brown lesions on his legs, diagnosed as classic sporadic Kaposi’s sarcoma. What demographic is most typically affected by this subtype?",
    options: [
      "Young women from Central Africa.",
      "Older men of Jewish or Mediterranean ancestry.",
      "HIV-positive individuals regardless of gender.",
      "Immunocompromised transplant recipients."
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! Classic sporadic Kaposi’s sarcoma primarily occurs in older men, particularly those of Jewish or Mediterranean descent, distinguishing it from other KS subtypes.",
    incorrectFeedback: "Consider the specific risk factors for different subtypes of KS. Which ethnic or demographic group is most commonly associated with classic sporadic KS?"
  },
  {
    question: "What is the recommended approach for managing visceral involvement in Kaposi’s sarcoma?",
    options: [
      "Only surgical resection if symptomatic.",
      "Start systemic chemotherapy if extensive disease is present.",
      "Exclusive use of radiotherapy for all patients.",
      "Observation with no active treatment."

    ],
    correctAnswer: 2,
    correctFeedback: "Correct! If there is extensive visceral involvement or symptomatic edema, systemic chemotherapy is indicated to manage Kaposi’s sarcoma effectively.",
    incorrectFeedback: "Reflect on the severity of visceral involvement in KS. What types of therapies are generally employed in cases where lesions lead to significant complications?"
  }
]} />